Company name DineEquity, Inc.
Stock ticker DIN
Live stock price [stckqut]DIN[/stckqut]
Confident Investor Rating Poor

The following company description is from Google Finance: http://www.google.com/finance?q=din

DineEquity, Inc. is engaged in the development, operation and franchising of International House of Pancakes (IHOP) restaurants. The Company owns, operates and franchises two restaurant concepts in the casual dining and family dining categories: Applebee’s Neighborhood Grill and Bar, and IHOP. The franchise operations segment consists of 1,609 restaurants operated by Applebee’s franchisees in the United States, one United States territory and 15 countries outside of the United States. The company restaurant operations segment consists of 398 company-operated restaurants in the United States and one company-operated restaurant in China. The franchise operations segment consists of 1,443 restaurants operated by IHOP franchisees and area licensees in the United States, two United States territories and two countries outside of the United States. The company restaurant operations segment consists of 12 company-operated restaurants in the United States.

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock. It is not possible to confidently invest in a company that is not currently profitable.

Company name DG FastChannel Inc.
Stock ticker DGIT
Live stock price [stckqut]DGIT[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $45.83
Target stock price (averages with growth) $81.4
Target stock price (averages with no growth) $73.69
Target stock price (manual assumptions) $45.05

The following company description is from Google Finance: http://www.google.com/finance?q=dgit

DG FastChannel, Inc. (DGF) is a provider of digital technology services, which enables the electronic delivery of advertisements, syndicated programs, and video news releases to broadcasters, online publishers and other media outlets. DGF operates three nationwide digital networks out of the network operation centers (NOCs), located in Irving, Texas (Irving NOC), Atlanta, Georgia (Atlanta NOC) and Jersey City, New Jersey (New Jersey NOC), which link more than 5,000 advertisers, advertising agencies and content owners with more than 23,000 radio, television, cable, network and print publishing destinations and over 5,000 online publishers electronically throughout the United States, Canada, and Europe. Through the NOCs, DGF delivers video, audio, image and data content that comprise transactions among advertisers, content owners, and various media outlets, including those in the broadcast industries.

Confident Investor comments: This stock price may be significantly undervalued. It has not recovered fully from its major decline in August and September of 2010. At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

Company name Cubist Pharmaceuticals, Inc.
Stock ticker CBST
Live stock price [stckqut]CBST[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Good
EPS growth Poor
P/E growth Fair
EBIT growth Poor
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $47.11
Target stock price (averages with growth) $48.02
Target stock price (averages with no growth) $20.36
Target stock price (manual assumptions) $47.35

The following company description is from Google Finance: http://www.google.com/finance?q=cbst

Cubist Pharmaceuticals, Inc. (Cubist) is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The Company?s products are used primarily in hospitals, but also may be used in acute care settings, including home infusion and hospital outpatient clinics. As of December 31, 2010, Cubist?s derived all of its revenues from CUBICIN (daptomycin for injection), which is a once-daily, bactericidal, intravenous (I.V.) antibiotic with activity against certain Gram-positive organisms, including methicillin-resistant Staphylococcus aureus (S. aureus), (MRSA). As of December 31, 2010, CUBICIN had been used in the treatment of more than an estimated 1.1 million patients in the United States.

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

Company name bebe stores, inc.
Stock ticker BEBE
Live stock price [stckqut]BEBE[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Poor
Sales growth Poor
EPS growth Poor
P/E growth Poor
EBIT growth Poor
ANALYSIS
Confident Investor Rating Poor
Target stock price (TWCA growth scenario) $0.52
Target stock price (averages with growth) $1.5
Target stock price (averages with no growth) $2.28
Target stock price (manual assumptions) $15.36

The following company description is from Google Finance: http://www.google.com/finance?q=bebe

bebe stores, inc. designs, develops and produces a line of contemporary women’s apparel and accessories. The Company?s product offering includes a range of separates, tops, dresses, active wear and accessories in the lifestyle categories, such as career, evening, casual and active. It designs and develops the majority of its merchandise in-house, which is manufactured to the Company?s specifications, or is sourced directly from third-party manufacturers. As of July 3, 2010, the Company marketed its products under the bebe, BEBE SPORT, bbsp, PH8 and 2b bebe brand names through its 297 retail stores, its online store at www.bebe.com, and its 49 international licensee operated stores. As of September 2010, the Company?s store operations were organized into four regions and 32 districts.

Confident Investor comments: I realize that the stock price of this company has done quite well over the past year and that many analysts have a very nice growth target on this company. At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock.

Company name Atlas Pipeline Partners, L.P.
Stock ticker APL
Live stock price [stckqut]APL[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $49.92
Target stock price (averages with growth) $33.98
Target stock price (averages with no growth) $13.35
Target stock price (manual assumptions) $50.2

The following company description is from Google Finance: http://www.google.com/finance?q=apl

Atlas Pipeline Partners, L.P. (the Partnership) is a provider of natural gas gathering, processing and treating services in the Anadarko and Permian Basins located in the southwestern and mid-continent regions of the United States and a provider of natural gas gathering services in the Appalachian Basin in the northeastern region of the United States. The Company conducts its business in the midstream segment of the natural gas industry through two segments: Mid-Continent and Appalachia. The Partnership?s operations are conducted through subsidiary entities whose interests are owned by Atlas Pipeline Operating Partnership, L.P. (the Operating Partnership), a wholly owned subsidiary of the Partnership. Its partner, Atlas Pipeline Partners GP, LLC (the General Partner), manages its operations and activities through its ownership of its general partner interest.

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.